Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B - Hoffmann, Christopher J; Charalambous, Salome; Thio, Chloe L; Martin, Desmond J; Pemba, Lindiwe; Fielding, Katherine L; Churchyard, Gavin J; Chaisson, Richard E; Grant, Alison D (AIDS (London), 2007)
Keywords: Adult; Alanine Transaminase - analysis; Anti-HIV Agents - administration & dosage; Anti-HIV Agents - adverse effects; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antitubercular Agents - therapeutic use; Antiviral agents; Aspartate Aminotransferases - analysis; Biological and medical sciences; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Drug toxicity and drugs side effects treatment; Female; Hepatitis B - immunology; Hepatitis B Surface Antigens - blood; HIV Infections - complications; HIV Infections - drug therapy; HIV Infections - immunology; Human immunodeficiency virus; Human viral diseases; Humans; Incidence; Infectious diseases; Liver - drug effects; Liver - enzymology; Male; Medical sciences; Middle Aged; Mycobacterium; Occupational Diseases - drug therapy; Occupational Diseases - epidemiology; Occupational Diseases - immunology; Pharmacology. Drug treatments; Retrospective Studies; South Africa - epidemiology; Toxicity: digestive system; Treatment Outcome; Tuberculosis - complications; Tuberculosis - drug therapy; Tuberculosis - epidemiology; Viral diseases; Viral diseases of the lymphoid tissue and the blood. Aids; South Africa; Africa; Antiretroviral agent; Benzoxazine derivatives; RNA-directed DNA polymerase; Acetylenic compound; Toxicity; hepatitis B; Non nucleoside compound; toxic hepatitis; Hepatic disease; Mycobacterial infection; Efavirenz; Viral hepatitis B; Reverse transcriptase inhibitor; Nucleoside analog; Antiviral; Pyrimidine nucleoside; Hepatotoxicity; Viral hepatitis C; Immunopathology; Alanine; Enzyme; Transferases; Enzyme inhibitor; Lamivudine; AIDS; Immune deficiency; Infection; Allosteric inhibitor; Nucleotidyltransferases; Chemotherapy; Treatment; Tuberculosis; HIV; Aminoacid; Dideoxynucleoside; Viral disease; Bacteriosis; Digestive diseases; Zidovudine; HAART